Empery Asset Management LP recently announced the acquisition of new stake in Aethlon Medical Inc. (NASDAQ:AEMD). The institutional investor has increased its shareholding in the Healthcare company by 1,558.86% to 0.51 million shares with purchase of 0.48 million shares. This fresh investment now brings its stake to 5.41% valued currently at $0.74 million. In addition, The Vanguard Group, Inc. raised its holdings by 0.11 million to 0.12 million shares. And Iroquois Capital Management LLC has lifted its position by 10.70% or 10700.0 shares – to 0.11 million shares.
With over 0.44 million Aethlon Medical Inc. (AEMD) shares trading Wednesday and a closing price of $1.78 on the day, the dollar volume was approximately $0.78 million. The shares have shown a negative weekly performance of -12.32% and its price on 07/08/20 lost nearly -3.78%. Currently, there are 8.20M common shares owned by the public.
Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 5 of these insider trades were purchases, accounting for 119,465 shares. Insider sales of the common stock occurred on 20 occasions, with total insider shares sold totaling 28,994 shares.
The top 3 mutual fund holders in Aethlon Medical Inc. are Vanguard Extended Market Index Fu, Fidelity Series Total Market Inde, and Fidelity Extended Market Index Fu. Vanguard Extended Market Index Fu owns 0.12 million shares of the company’s stock, all valued at over $0.18 million. The company has a total holdings of about 1.31% of the shares outstanding. Fidelity Series Total Market Inde bought 8866.0 shares to see its total holdings to 8866.0 shares valued at over $13033.0 and representing 0.10% of the shares outstanding. Fidelity Extended Market Index Fu has total holdings to over 5590.0 shares at a value of $8217.0. Fidelity Extended Market Index Fu now owns shares totaling to 0.06% of the shares outstanding.
Shares of Aethlon Medical Inc. (NASDAQ: AEMD) opened at $1.82, down -$0.03 from a prior closing price of $1.85. However, the script later closed the day at $1.78, down -3.78%. The company’s stock has a 5-day price change of -12.32% and 37.98% over the past three months. AEMD shares are trading 84.84% year to date (YTD), with the 12-month market performance down to -67.93% lower. It has a 12-month low price of $0.76 and touched a high of $6.89 over the same period. Currently, 0.44 million shares have been traded, compared to an average intraday trading volume of 2.53 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.82%, 13.23%, and -24.64% respectively.
Institutional ownership of Aethlon Medical Inc. (NASDAQ: AEMD) shares accounts for 11.20% of the company’s 8.20M shares outstanding. Mutual fund holders own 1.50%, while other institutional holders and individual stakeholders account for 9.52% and 0.47% respectively.
It has a market capitalization of $21.64M and a beta (3y monthly) value of 0.68. The stock’s earnings-per-share (ttm) stands at -$3.42. The company has a Quick Ratio of 9.40 with the debt-to-equity ratio at 0.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.67% over the week and 16.03% over the month.
Analysts forecast that Aethlon Medical Inc. (AEMD) will achieve an EPS of $0 for the current quarter, $0 for the next quarter and $0 for Next Year. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Earnings per share for the fiscal year are expected to increase by 63.60%. EPS over the next five years should compared to 36.60% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by several brokerage firm advisors rate Aethlon Medical Inc. (AEMD) as a “Moderate Buy” at a consensus score of 2.00.